- Trials with a EudraCT protocol (25)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
25 result(s) found for: Gallbladder disorders.
Displaying page 1 of 2.
| EudraCT Number: 2008-005135-15 | Sponsor Protocol Number: 8101 colloidAug08 | Start Date*: 2009-01-12 | ||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:University of Nottingham | ||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: Do 100 kiloDaltons matter? A prospective randomised double-blind study on the blood volume expanding effects of two different colloids in patients undergoing laparoscopic cholecystectomy | ||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: Patients undergoing laparoscopic cholecystectomy | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2007-000271-42 | Sponsor Protocol Number: 11012007 | Start Date*: 2007-05-08 | |||||||||||
| Sponsor Name:Matti Eskelinen | |||||||||||||
| Full Title: OKSIKODONIN ANALGEETTINEN PITOISUUS PLASMASSA YHDESSÄ PARASETAMOLIN 1g TAI 2g IV KANSSA ANNETTUNA MAHAKIRURGISILLA POTILAILLA | |||||||||||||
| Medical condition: Tutkimukseen otetaan 24 sappileikkaukseen tulevaa perustervettä aikuispotilasta. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: FI (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2004-004316-23 | Sponsor Protocol Number: CLOMG | Start Date*: 2004-11-12 | |||||||||||
| Sponsor Name:OSPEDALE S. RAFFAELE | |||||||||||||
| Full Title: Randomised, controlled , double blind trial on emodinamic, analgesic, pharmacoeconomic effects of clonidine and magnesium in premedication of laparoscopic surgery for colecitis ablation. | |||||||||||||
| Medical condition: Post operative analgesia. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-004878-29 | Sponsor Protocol Number: NA | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:St. Antonius Hospital | |||||||||||||
| Full Title: Perioperative antibiotic use in the treatment of acute calculous cholecystitis | |||||||||||||
| Medical condition: Acute calculous cholecystitis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-021240-18 | Sponsor Protocol Number: ARHSG062010 | Start Date*: 2011-04-19 | |||||||||||
| Sponsor Name:AZIENDA OSPEDALIERA S. GERARDO DI MONZA | |||||||||||||
| Full Title: Peritoneal nebulization of Ropivacaine for pain control after laparoscopic colectomy | |||||||||||||
| Medical condition: Elective Laparoscopic colectomy | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-004692-53 | Sponsor Protocol Number: SJ-434 | Start Date*: 2017-03-01 | ||||||||||||||||||||||||||
| Sponsor Name:Zealand University Hospital Køge | ||||||||||||||||||||||||||||
| Full Title: Changes in bile acid homeostasis and stool habits after cholecystectomy | ||||||||||||||||||||||||||||
| Medical condition: Post cholecystectomy bile acid diarrhoea/malabsorption | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
| Trial protocol: DK (Completed) | ||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||
| EudraCT Number: 2015-000825-35 | Sponsor Protocol Number: U1111-1167-2731 | Start Date*: 2015-08-27 | |||||||||||
| Sponsor Name:Rigshospitalet Blegdamsvej | |||||||||||||
| Full Title: The effect of the glucagon-like peptide-1 analogue, liraglutide (Victoza®), on jejunostomy output and intestinal absorption in short bowel syndrome patients, a double-blind cross-over study | |||||||||||||
| Medical condition: Short bowel syndrome (SBS) is a clinical situation with reduced absorptive mucosal surface due to extensive surgical resection. SBS leads to increased intestinal losses of fluids and electrolytes; ... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-012398-36 | Sponsor Protocol Number: a003c | Start Date*: 2009-06-18 | |||||||||||||||||||||
| Sponsor Name:Helsinki University Hospital | |||||||||||||||||||||||
| Full Title: Patient-controlled sedation with propofol in ERCP:alfentanyl vs remifentanyl | |||||||||||||||||||||||
| Medical condition: Billiar tract and pancreatic disoderes | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: FI (Completed) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2014-002630-31 | Sponsor Protocol Number: CSOM230C2413 | Start Date*: 2015-03-25 | |||||||||||
| Sponsor Name:Novartis Pharma Services AG | |||||||||||||
| Full Title: A phase IIIb multicenter, open-label, single arm study to evaluate the efficacy and safety of pasireotide in patients with acromegaly inadequately controlled with first generation somatostatin ana... | |||||||||||||
| Medical condition: Acromegaly | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Completed) BE (Completed) PT (Completed) IT (Completed) FR (Completed) BG (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2020-005513-41 | Sponsor Protocol Number: TA799-012 | Start Date*: 2021-04-19 | |||||||||||
| Sponsor Name:VectivBio AG | |||||||||||||
| Full Title: An open-label extension trial to evaluate the long-term safety of apraglutide in short bowel syndrome | |||||||||||||
| Medical condition: short bowel syndrome | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Trial now transitioned) CZ (Trial now transitioned) DE (Trial now transitioned) FR (Trial now transitioned) ES (Ongoing) IT (Trial now transitioned) HU (Trial now transitioned) DK (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2008-007968-42 | Sponsor Protocol Number: a001c | Start Date*: 2009-02-13 | |||||||||||||||||||||||||||||||
| Sponsor Name:Helsinki University Central Hospital | |||||||||||||||||||||||||||||||||
| Full Title: Patient-controlled sedation vs propofol infusion for ERCP | |||||||||||||||||||||||||||||||||
| Medical condition: ERCP (Endoscopic Retrograde Cholangiopancreatography) | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
| Trial protocol: FI (Completed) | |||||||||||||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||||||||||||
| EudraCT Number: 2014-002389-62 | Sponsor Protocol Number: 8-55-52030-309 | Start Date*: 2015-03-02 | |||||||||||
| Sponsor Name:Ipsen Group | |||||||||||||
| Full Title: Phase IIa, open label, dose ascending study to determine the maximum tolerated dose, safety and tolerability, pharmacokinetics and pharmacodynamics of a single dose of lanreotide PRF in subjects wi... | |||||||||||||
| Medical condition: Acromegaly | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) BE (Completed) DE (Completed) NL (Completed) CZ (Completed) LT (Completed) ES (Completed) IT (Completed) PL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-000297-72 | Sponsor Protocol Number: 2-55-52030-727 | Start Date*: 2007-04-24 | |||||||||||
| Sponsor Name:BEAUFOUR IPSEN Pharma | |||||||||||||
| Full Title: Phase III, multicentre, open study to assess the efficacy and safety profiles of the co-administration of lanreotide Autogel 120 mg (administered via deep subcutaneous injections every 28 days) and... | |||||||||||||
| Medical condition: Acromegaly | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) GR (Completed) DE (Completed) CZ (Completed) DK (Completed) IT (Completed) GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2022-001500-18 | Sponsor Protocol Number: 1403-0011 | Start Date*: 2022-11-07 | ||||||||||||||||
| Sponsor Name:Boehringer Ingelheim España S.A. | ||||||||||||||||||
| Full Title: Brightline-2: A Phase IIa/IIb, open-label, single-arm, multi-centre trial of BI 907828 for treatment of patients with locally advanced / metastatic, MDM2 amplified, TP53 wild-type biliary tract ade... | ||||||||||||||||||
| Medical condition: cancer in the biliary tract or pancreas | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: ES (Ongoing) BE (Trial now transitioned) NO (Prematurely Ended) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2013-000533-12 | Sponsor Protocol Number: HS-12-455 | Start Date*: 2014-07-02 | ||||||||||||||||
| Sponsor Name:Camurus AB | ||||||||||||||||||
| Full Title: A Phase II, Open-label, Multicentre, Randomised Study of the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of CAM2029 in Two Patient Groups with Acromegaly and Neuroendocrine Tumours (NE... | ||||||||||||||||||
| Medical condition: acromegaly; neuroendocrine tumours | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: DE (Completed) IT (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2007-000155-34 | Sponsor Protocol Number: 2 79 52030 207 | Start Date*: 2008-06-02 | |||||||||||
| Sponsor Name:Beaufour Ipsen Pharma | |||||||||||||
| Full Title: PHASE IIIb, MULTICENTRE, OPEN-LABEL, SINGLE-ARM, STUDY TO ASSESS THE EFFICACY AND SAFETY OF LANREOTIDE AUTOGEL 120 mg ADMINISTERED EVERY 28 DAYS AS PRIMARY MEDICAL TREATMENT IN ACROMEGALIC PATIENTS... | |||||||||||||
| Medical condition: ACROMEGALY ASSOCIATED WITH PITUITARY GLAND MACROADENOMA | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Completed) FR (Completed) ES (Prematurely Ended) SE (Completed) GB (Completed) BE (Completed) CZ (Completed) FI (Completed) DE (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-004762-83 | Sponsor Protocol Number: BILISCOPIN | Start Date*: 2008-10-15 | ||||||||||||||||||||||||||
| Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | ||||||||||||||||||||||||||||
| Full Title: Evaluation of the diagnostic efficacy of the CT cholangiography performed by administering an intra-venous contrast medium with biliary excretion (Biliscopin) in patients with malignancies of the b... | ||||||||||||||||||||||||||||
| Medical condition: Patients with obstructive jaundice due to a biliary malignancy (Klatskin tumor, tumor of the middle or distal bile ducts or Galbladder tumors) Patients with post-cholecistectomy iatrogenic lesions ... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
| Trial protocol: IT (Ongoing) | ||||||||||||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||||||||||||
| EudraCT Number: 2008-005604-54 | Sponsor Protocol Number: NXL104/2002 | Start Date*: 2009-04-10 | ||||||||||||||||
| Sponsor Name:Novexel, S.A. | ||||||||||||||||||
| Full Title: A prospective, multicentre, double-blind, randomized, comparative study to estimate the safety, tolerability and efficacy of NXL104/ceftazidime plus metronidazole vs. meropenem in the treatment of ... | ||||||||||||||||||
| Medical condition: Complicated intra-abdominal infections (cIAI) in hospitalised adults | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: BG (Completed) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2015-005216-15 | Sponsor Protocol Number: ABO-NB-15 | Start Date*: 2016-07-06 | |||||||||||||||||||||
| Sponsor Name:ABOCA S.P.A. SOCIETà AGRICOLA | |||||||||||||||||||||||
| Full Title: Relief of heartburn and epigastric pain comparing Neobianacid® with omeprazole: a randomized, double blind, double dummy, reference product controlled, parallel group, non-inferiority clinical study | |||||||||||||||||||||||
| Medical condition: GERD (Gastroesophageal Reflux Disease) and/or EPS (Epigastric Pain Syndrome) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2019-002190-66 | Sponsor Protocol Number: HS-19-647 | Start Date*: 2019-07-12 | |||||||||||
| Sponsor Name:Camurus AB | |||||||||||||
| Full Title: A Phase 3, open-label, single-arm, multi-center trial to assess the long term safety of octreotide subcutaneous depot (CAM2029) in patients with acromegaly | |||||||||||||
| Medical condition: Acromegaly | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Trial now transitioned) DE (Trial now transitioned) GB (GB - no longer in EU/EEA) PL (Trial now transitioned) ES (Ongoing) GR (Completed) IT (Trial now transitioned) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.